公开(公告)号：US20200337257A1

公开(公告)日：2020-10-29

申请号：US16928581

申请日：2020-07-14

Applicant: Lalit Kumar

Inventor： Lalit Kumar

IPC: A01G25/16 ,  G01N27/12

Abstract: A moisture monitoring system with internes of things devices. The system includes at least one irrigating device having a moisture sensor, a temperature sensor, a valve connected to a water source, a wireless transmitter that sends sensor information to a cloud server via a first internet-of-things establishing a first channel of communication, and a wireless receiver configured to receive valve actuation signals from the cloud server via a second internet-of-things device establishing a second channel of communication. A valve actuator opens the valve upon receiving an actuation signal via the second internet-of-things device. The duration of the valve remaining open and other parameters are adjustable by a user utilizing a user interface of the second internet-of-things device. The moisture monitoring system can be customized and applied to various use cases depending on the irrigation needs of the user.

公开(公告)号：US20190037787A1

公开(公告)日：2019-02-07

申请号：US16047120

申请日：2018-07-27

Applicant: Lalit Kumar

Inventor： Lalit Kumar

IPC: A01G25/16 ,  A01G25/06 ,  G01N33/24 ,  G01K3/00

Abstract: A moisture meter having a housing with a stake disposed at a lower end thereof. A moisture sensor and a temperature sensor disposed on the stake. The moisture meter includes a valve wherein a water source is removably secured thereto. The stake includes a channel between the valve and a tip of the stake, allowing liquid to flow therethrough. Alternatively, the valve can be mounted on a wall or adjacent to a water line, wherein the stake can be connected to valve by a water hose. A wireless transmitter is disposed within the sensor housing and can transmit the moisture and temperature readings from the moisture and temperature sensors to an external source. A wireless receiver is disposed within the valve housing in order to actuate the valve, allowing water to flow through the stake and into the ground, should the moisture and temperature readings reach a pre-set level.

公开(公告)号：US20170303480A1

公开(公告)日：2017-10-26

申请号：US15491007

申请日：2017-04-19

Applicant: Lalit Kumar

Inventor： Lalit Kumar

IPC: A01G27/00

CPC classification number: A01G9/28 ,  A01G25/00

Abstract: A water containment device. The water containment device provides a bendable strip for containing water around plants. The strip includes interlocking slots or other fasteners for creating a closed loop or connecting with a second similar strip. The strip also includes teeth on a bottom side that are configured to penetrate and engage a ground surface to keep the strip in an upright orientation. Once secured around a plant, the strip prevents water from leaving from a close proximity from the surface or the top soil around the plant.

公开(公告)号：US09237103B2

公开(公告)日：2016-01-12

申请号：US13435023

申请日：2012-03-30

Applicant: Deepak Srinivas Mayya ,  Rajesh L G ,  Saket Jain ,  Prashant Chandrashekhar Pathak ,  Lalit Kumar ,  Ranganathan Rajagopalan

Inventor： Deepak Srinivas Mayya ,  Rajesh L G ,  Saket Jain ,  Prashant Chandrashekhar Pathak ,  Lalit Kumar ,  Ranganathan Rajagopalan

IPC: H04L12/26 ,  H04L12/801 ,  H04L12/841 ,  H04L12/835 ,  H04L12/823

CPC classification number: H04L47/12 ,  H04L47/17 ,  H04L47/28 ,  H04L47/30 ,  H04L47/32 ,  H04L47/39

Abstract: In one embodiment, a method is provided for alleviating congestion in a network system. In this method, the receipt of data packets destined for a destination apparatus is detected. Flow control signals are also received with each flow control signal corresponding to a data packet. Various time periods are tracked with each time period being between the detection of the receipt of a data packet and the receipt of tracked corresponding flow control signal. An average of the time periods is calculated and this average is compared to a threshold. One or more data packets are dropped in reference to the comparison.

Abstract translation: 在一个实施例中，提供了一种用于减轻网络系统中的拥塞的方法。 在该方法中，检测到目的地为目的地设备的数据分组的接收。 流量控制信号也被接收，每个流量控制信号对应于一个数据包。 跟踪每个时间段，每个时间段在检测到数据分组的接收和跟踪的对应的流量控制信号的接收之间。 计算时间段的平均值，并将该平均值与阈值进行比较。 参考比较，丢弃一个或多个数据包。

公开(公告)号：US20130258851A1

公开(公告)日：2013-10-03

申请号：US13435350

申请日：2012-03-30

Applicant: Deepak Srinivas Mayya ,  Rajesh L G ,  Saket Jain ,  Prashant Chandrashekhar Pathak ,  Lalit Kumar ,  Ranganathan Rajagopalan

Inventor： Deepak Srinivas Mayya ,  Rajesh L G ,  Saket Jain ,  Prashant Chandrashekhar Pathak ,  Lalit Kumar ,  Ranganathan Rajagopalan

IPC: H04L12/26

CPC classification number: H04L47/32 ,  H04L47/12 ,  H04L47/17 ,  H04L47/28 ,  H04L47/39

Abstract: In one embodiment, a method is provided for controlling congestion in a network system. In this method, receipt of a data packet that is destined for a destination switching apparatus is detected. Subsequent to the detection of the data packet, a time that has elapsed while flow control is implemented by the destination switching apparatus is tracked. The data packet is dropped based on the elapsed time exceeding a predefined time period.

Abstract translation: 在一个实施例中，提供了一种用于控制网络系统中的拥塞的方法。 在该方法中，检测到目的地为目的地交换装置的数据分组的接收。 在检测到数据包之后，跟踪由目的地交换装置实现流量控制所经过的时间。 基于超过预定时间段的经过时间，丢弃数据包。

公开(公告)号：US20080280926A1

公开(公告)日：2008-11-13

申请号：US10596528

申请日：2004-12-16

Applicant: Venkata P. Palle ,  Sarala Balachandran ,  Mohammad Salman ,  Gagan Kukreja ,  Lalit Kumar Baregama ,  Abhijit Ray ,  Sunanda Ghosh Dastidar

Inventor： Venkata P. Palle ,  Sarala Balachandran ,  Mohammad Salman ,  Gagan Kukreja ,  Lalit Kumar Baregama ,  Abhijit Ray ,  Sunanda Ghosh Dastidar

IPC: C07D473/34 ,  A61K31/52 ,  A61P37/00 ,  A61P29/00 ,  A61P31/12 ,  A61P11/00 ,  A61P19/02 ,  A61P1/00

CPC classification number: C07D473/00

Abstract: The present invention relates to purine derivatives, which can be used as selective phosphodiesterase (PDE) type IV inhibitors. Compounds disclosed herein can be useful in the treatment of asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Also provided are processes for the preparation of disclosed compounds, pharmaceutical composition containing the disclosed compounds and their use as selective phosphodiesterase (PDE) type IV inhibitors.

Abstract translation: 本发明涉及可用作选择性磷酸二酯酶（PDE）IV型抑制剂的嘌呤衍生物。 本文公开的化合物可用于治疗哮喘，关节炎，支气管炎，慢性阻塞性肺疾病（COPD），牛皮癣，过敏性鼻炎，休克，特应性皮炎，克罗恩病，成人呼吸窘迫综合征（ARDS），嗜酸性肉芽肿，过敏性结膜炎 ，骨关节炎，溃疡性结肠炎和其他炎性疾病，特别是人类。 还提供了制备所公开的化合物的方法，含有所公开的化合物的药物组合物及其作为选择性磷酸二酯酶（PDE）IV型抑制剂的用途。

公开(公告)号：US20130085639A1

公开(公告)日：2013-04-04

申请号：US13252365

申请日：2011-10-04

Applicant: Lalit Kumar Sethi ,  Ermal Gjoni ,  Hector Hernandaz ,  Roy Gammouh

Inventor： Lalit Kumar Sethi ,  Ermal Gjoni ,  Hector Hernandaz ,  Roy Gammouh

IPC: B62D6/00 ,  G06F19/00

CPC classification number: B60T8/17555 ,  B60T2201/122 ,  B60T2210/36 ,  B60T2260/02

Abstract: A method of controlling stability of a vehicle comprises monitoring vehicle information with an electronic control unit. An approaching unstable driving condition is detected from the vehicle information with an electronic control unit. A signal is sent from the electronic control unit to at least one vehicle system to apply at least one proactive vehicle stability control action prior to the occurrence of the unstable driving condition.

Abstract translation: 一种控制车辆的稳定性的方法包括用电子控制单元监控车辆信息。 利用电子控制单元从车辆信息中检测到接近的不稳定驾驶状况。 信号从电子控制单元发送到至少一个车辆系统，以在发生不稳定驾驶状况之前施加至少一个主动车辆稳定性控制动作。

公开(公告)号：US20110174007A1

公开(公告)日：2011-07-21

申请号：US12834113

申请日：2010-07-12

Applicant: Lalit Kumar

Inventor： Lalit Kumar

IPC: F25D23/00 ,  B23P11/00 ,  F16L3/08

CPC classification number: B23P15/00 ,  B29C45/18 ,  B29L2031/18 ,  F23D14/34 ,  F23D14/58 ,  F23D2900/14481 ,  F24H3/087 ,  F24H8/006 ,  F24H9/2035 ,  F25D21/14 ,  Y02B30/106 ,  Y10T29/49 ,  Y10T29/49348 ,  Y10T29/4935 ,  Y10T29/49389 ,  Y10T29/49826 ,  Y10T137/4463

Abstract: Provided, in aspect, is a suspension bracket for use with an HVAC component. The suspension bracket, in one embodiment, may include a base portion, a first tab portion coupled to the base portion, wherein the first tab portion is positioned substantially perpendicular to the base portion, and a second tab portion coupled to the base portion. The second tab portion, in this embodiment, may include a first region and a second region, wherein the first region is positioned substantially perpendicular to the base portion, and further wherein the second region is positioned substantially perpendicular to the base portion and the first region.

Abstract translation: 在方面，提供了一种用于HVAC部件的悬挂支架。 在一个实施例中，悬挂托架可以包括基部，联接到基部的第一突片部分，其中第一突片部分基本上垂直于基部定位，以及耦合到基部的第二突片部分。 在该实施例中，第二突片部分可以包括第一区域和第二区域，其中第一区域基本上垂直于基部定位，并且其中第二区域基本上垂直于基部和第一区域 。

公开(公告)号：US20110130403A1

公开(公告)日：2011-06-02

申请号：US12531045

申请日：2008-03-13

Applicant: Sonali Rudra ,  Nidhi Gupta ,  Lalit Kumar Baregama ,  Ritu Agarwal ,  Mandadapu Raghuramaiah ,  Vinayak Vasantrao Khairnar ,  Venkata P. Palle ,  Sarala Balachandran ,  Abhijit Ray ,  Sunada G. Dastidar ,  Lalitha Vijaykrishnan

Inventor： Sonali Rudra ,  Nidhi Gupta ,  Lalit Kumar Baregama ,  Ritu Agarwal ,  Mandadapu Raghuramaiah ,  Vinayak Vasantrao Khairnar ,  Venkata P. Palle ,  Sarala Balachandran ,  Abhijit Ray ,  Sunada G. Dastidar ,  Lalitha Vijaykrishnan

IPC: A61K31/437 ,  C07D471/04 ,  A61K31/444 ,  A61K31/497 ,  A61K31/506 ,  A61K31/53 ,  A61P29/00 ,  A61P37/06 ,  A61P25/00

CPC classification number: C07D471/04

Abstract: The present invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7 and dual PDE type 4/PDE type 7 inhibitors. Compounds disclosed hereinf having the structure of Formula I: can be useful in the treatment, prevention, inhibition or suppression of CNS diseases, for example, multiple sclerosis; various pathological conditions such as diseases affecting the immune system, including AIDS, rejection of transplant, auto-immune disorders such as T-cell related diseases, for example, rheumatoid arthritis; inflammatory diseases such as respiratory inflammation diseases including chronic obstructive pulmonary disease (COPD), asthma, bronchitis, allergic rhinitis, adult respiratory distress syndrome (ARDS) and other inflammatory diseases including but not limited to psoriasis, shock, atopic dermatitis, eosinophilic granuloma, allergic conjunctivitis, osteoarthritis; gastrointestinal inflammation diseases such as Crohn's disease, colitis, pancreatitis as well as different types of cancers including leukaemia; especially in humans. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and their use as PDE type 4, PDE type 7 and dual PDE t e 4/PDE t e 7 inhibitors are rovided.

Abstract translation: 本发明涉及磷酸二酯酶（PDE）4型，磷酸二酯酶（PDE）7型和双重PDE型4 / PDE型7型抑制剂。 本文公开的具有式I结构的化合物可用于治疗，预防，抑制或抑制CNS疾病，例如多发性硬化; 各种病理状况如影响免疫系统的疾病，包括艾滋病，移植排斥反应，自身免疫性疾病如T细胞相关疾病，例如类风湿性关节炎; 炎性疾病如呼吸道炎症疾病，包括慢性阻塞性肺疾病（COPD），哮喘，支气管炎，过敏性鼻炎，成人呼吸窘迫综合征（ARDS）和其他炎性疾病，包括但不限于银屑病，休克，特应性皮炎，嗜酸性肉芽肿，过敏性 结膜炎，骨关节炎; 胃肠道炎症性疾病如克罗恩病，结肠炎，胰腺炎以及不同类型的癌症，包括白血病; 特别是在人类。 制备所公开的化合物的方法，包含所公开的化合物的药物组合物及其作为PDE 4型，PDE型7和双重PDE 4 / PDE 7抑制剂的用途是有争议的。

公开(公告)号：US20100292196A1

公开(公告)日：2010-11-18

申请号：US12531043

申请日：2008-03-14

Applicant: Sonali Rudra ,  Nidhi Gupta ,  Lalit Kumar Baregama ,  Ritu Agarwal ,  Vinayak Vasantrao Khairnar ,  Mandadapu Raghu Ramaiah ,  Venkata P. Palle ,  Sarala Balachandran ,  Atul Kondaskar ,  Manohar Salla ,  Abhijit Ray ,  Sunanda G. Dastidar ,  Lalitha Vijaykrishnan

Inventor： Sonali Rudra ,  Nidhi Gupta ,  Lalit Kumar Baregama ,  Ritu Agarwal ,  Vinayak Vasantrao Khairnar ,  Mandadapu Raghu Ramaiah ,  Venkata P. Palle ,  Sarala Balachandran ,  Atul Kondaskar ,  Manohar Salla ,  Abhijit Ray ,  Sunanda G. Dastidar ,  Lalitha Vijaykrishnan

IPC: A61K31/573 ,  C07D519/00 ,  A61K31/437 ,  C07D471/04 ,  A61P17/00 ,  A61P19/00 ,  A61P11/00 ,  A61P35/00

CPC classification number: C07D471/04 ,  C07D519/00

Abstract: The present invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7 and dual PDE type 4/PDE type 7 inhibitors. Compounds disclosed herein having the structure of Formula 1: can be useful in the treatment, prevention, inhibition or suppression of CNS diseases, for example, multiple sclerosis; various pathological conditions such as diseases affecting the immune system, including AIDS, rejection of transplant, auto-immune disorders such as T-cell related diseases, for example, rheumatoid arthritis; inflammatory diseases such as respiratory inflammation diseases including chronic obstructive pulmonary disease (COPD), asthma, bronchitis, allergic rhinitis, adult respiratory distress syndrome (ARDS) and other inflammatory diseases including but not limited to psoriasis, shock, atopic dermatitis, eosinophilic granuloma, allergic conjunctivitis, osteoarthritis; gastrointestinal inflammation diseases such as Crohn's disease, colitis, pancreatitis as well as different types of cancers including leukaemia; especially in humans. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and their use as PDE type 4, PDE type 7 and dual PDE type 4/PDE type 7 inhibitors are provided.

Abstract translation: 本发明涉及磷酸二酯酶（PDE）4型，磷酸二酯酶（PDE）7型和双重PDE型4 / PDE型7型抑制剂。 本文公开的具有式1结构的化合物可用于治疗，预防，抑制或抑制CNS疾病，例如多发性硬化; 各种病理状况如影响免疫系统的疾病，包括艾滋病，移植排斥反应，自身免疫性疾病如T细胞相关疾病，例如类风湿性关节炎; 炎性疾病如呼吸道炎症疾病，包括慢性阻塞性肺疾病（COPD），哮喘，支气管炎，过敏性鼻炎，成人呼吸窘迫综合征（ARDS）和其他炎性疾病，包括但不限于银屑病，休克，特应性皮炎，嗜酸性肉芽肿，过敏性 结膜炎，骨关节炎; 胃肠道炎症性疾病如克罗恩病，结肠炎，胰腺炎以及不同类型的癌症，包括白血病; 特别是在人类。 提供了制备所公开的化合物的方法，含有所公开的化合物的药物组合物及其作为PDE 4型，PDE型7和双重PDE型4 / PDE 7型抑制剂的用途。